Cargando…

Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements

OBJECTIVES: Despite the publication of hundreds of trials on gout and hyperuricemia, management of these conditions remains suboptimal. We aimed to assess the quality and consistency of guidance documents for gout and hyperuricemia. DESIGN: Systematic review and quality assessment using the appraisa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qianrui, Li, Xiaodan, Wang, Jing, Liu, Hongdie, Kwong, Joey Sum-Wing, Chen, Hao, Li, Ling, Chung, Sheng-Chia, Shah, Anoop, Chen, Yaolong, An, Zhenmei, Sun, Xin, Hemingway, Harry, Tian, Haoming, Li, Sheyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Diabetes and Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720466/ https://www.ncbi.nlm.nih.gov/pubmed/31446403 http://dx.doi.org/10.1136/bmjopen-2018-026677

Ejemplares similares

Diagnosis and treatment for hyperuricaemia and gout: a protocol for a systematic review of clinical practice guidelines and consensus statements
por: Li, Qianrui, et al.
Publicado: (2017)

Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis
por: Liu, Dan, et al.
Publicado: (2018)

Circulating Betatrophin in Patients with Type 2 Diabetes: A Meta-Analysis
por: Li, Sheyu, et al.
Publicado: (2016)

Susceptibility genes of hyperuricemia and gout
por: Nian, Yue-Li, et al.
Publicado: (2022)

Gout. Novel therapies for treatment of gout and hyperuricemia
por: Terkeltaub, Robert
Publicado: (2009)

Reporting quality of clinical practice guidelines regarding gout and hyperuricemia according to the RIGHT checklist: systematic review
por: Wang, Can, et al.
Publicado: (2021)

Development of Evidence-based Recommendations: Implications for Preparing Expert Consensus Statements
por: Kwong, Joey S W, et al.
Publicado: (2016)

Cardiovascular Safety of Febuxostat and Allopurinol in Hyperuricemic Patients With or Without Gout: A Network Meta-Analysis
por: Zhang, Shengzhao, et al.
Publicado: (2021)

Correction: Acetyl-L-carnitine in the Treatment of Peripheral Neuropathic Pain: A Systematic Review and Meta-analysis of Randomized Controlled Trials
por: Li, Sheyu, et al.
Publicado: (2015)

Acetyl-L-Carnitine in the Treatment of Peripheral Neuropathic Pain: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Li, Sheyu, et al.
Publicado: (2015)

Myopathy in hyperthyroidism as a consequence of rapid reduction of thyroid hormone: A case report
por: Li, Qianrui, et al.
Publicado: (2017)

Management of hyperuricemia in gout: focus on febuxostat
por: Reinders, Mattheus K, et al.
Publicado: (2010)

An update on the genetic architecture of hyperuricemia and gout
por: Merriman, Tony R
Publicado: (2015)

Pharmacological effects of Chatuphalatika in hyperuricemia of gout
por: Sato, Vilasinee Hirunpanich, et al.
Publicado: (2018)

The role of the Mediterranean diet in hyperuricemia and gout
por: Stamostergiou, Julie, et al.
Publicado: (2018)

Exploring RNA modifications, editing, and splicing changes in hyperuricemia and gout
por: Huang, Chung-Ming, et al.
Publicado: (2022)

Gout, not hyperuricemia alone, impairs left ventricular diastolic function
por: Lin, Jing-Chi, et al.
Publicado: (2015)

Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel
por: Buzzetti, Raffaella, et al.
Publicado: (2020)

The Interaction Between Dietary Fructose and Gut Microbiota in Hyperuricemia and Gout
por: Fang, Xin-yu, et al.
Publicado: (2022)

Potential Molecular Mechanisms of Plantain in the Treatment of Gout and Hyperuricemia Based on Network Pharmacology
por: Liu, Pei, et al.
Publicado: (2020)

A concise history of gout and hyperuricemia and their treatment
por: Nuki, George, et al.
Publicado: (2006)

Atypical musculoskeletal manifestations of gout in hyperuricemia patients
por: Sakti, Muhammad, et al.
Publicado: (2019)

Efficacy and safety of lesinurad for the treatment of hyperuricemia in gout
por: Pérez-Ruiz, Fernando, et al.
Publicado: (2019)

Performance of Ultrasound in the Clinical Evaluation of Gout and Hyperuricemia
por: Cao, Ling, et al.
Publicado: (2021)

Why Does Hyperuricemia Not Necessarily Induce Gout?
por: Zhang, Wei-Zheng
Publicado: (2021)

The biomarkers discovery of hyperuricemia and gout: proteomics and metabolomics
por: Wu, Xinghong, et al.
Publicado: (2023)

Incidental thyroid carcinoma in surgery-treated hyperthyroid patients with Graves’ disease: a systematic review and meta-analysis of cohort studies
por: Jia, Qingyi, et al.
Publicado: (2018)

Increased circulating full-length betatrophin levels in drug-naïve metabolic syndrome
por: Liu, Dan, et al.
Publicado: (2017)

N-Butyrylated hyaluronic acid ameliorates gout and hyperuricemia in animal models
por: Li, Lanzhou, et al.
Publicado: (2019)

Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout
por: Wang, Zhilei, et al.
Publicado: (2022)

Febuxostat in the management of hyperuricemia and chronic gout: a review
por: Hu, Miao, et al.
Publicado: (2008)

Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout
por: Gaffo, Angelo L, et al.
Publicado: (2010)

Febuxostat: A Novel Agent for Management of Hyperuricemia in Gout
por: Bisht, Manisha, et al.
Publicado: (2011)

Circulating microRNA alternations in primary hyperuricemia and gout
por: Bohatá, Jana, et al.
Publicado: (2021)

Treatment for hyperuricemia and gout in Japan: Aspect of prescription and duration
por: Zhang, Di
Publicado: (2022)

Associations of metal exposure with hyperuricemia and gout in general adults
por: Xu, Jing, et al.
Publicado: (2022)

Epidemiology and treatment-related concerns of gout and hyperuricemia in Korean
por: Ahn, Joong Kyong
Publicado: (2023)

Management of gout in chronic kidney disease: a G-CAN Consensus Statement on the research priorities
por: Stamp, Lisa K., et al.
Publicado: (2021)

Advances in the management of gout: Critical appraisal of febuxostat in the control of hyperuricemia
por: Beara-Lasic, Lada, et al.
Publicado: (2010)

The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout—An Update
por: Eckenstaler, Robert, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oj8jb1su6vgc1s82m2hvussfvq